
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Bolt Biotherapeutics, Inc
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing BoltbodyTM Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients. Bolts technology is appropriate for a broad spectrum of antibodies targeting tumor antigens expressed on all types of cancer and therefore applicable to many types of patients, including those who are refractory to the current generation of checkpoint inhibitors. The company is led by a team with extensive oncology drug discovery and development experience. Bolt was founded by Dr. Ed Engleman, and its platform is based on technology exclusively licensed from Stanford University. The company is financed by world-class investors including Novo Holdings, Pivotal bioV...
C-Level 1 | VP - Level- |
Director1 | Manager3 |
Others51 |
Structure | Email Format |
---|---|
<f><last>@ |
|
Pain Points | Locations | Technologies |
---|---|---|
Application Development | Redwood City, CA | communication, hoc, assessment, sox, financial, compliance, e, testing, collaboration, operations |
Build & Release | Redwood City, CA | communication, hoc, assessment, exchange, sox, audit, financial, e, compliance, testing, collaboration, operations |
Compliance | Redwood City, CA | communication, hoc, sox, audit, financial, compliance, testing, collaboration, operations |
Digital Transformation | Redwood City, CA | communication, hoc, assessment, exchange, sox, audit, financial, e, compliance, testing, collaboration, operations |
Embedded Design | Redwood City, CA | communication, e, assessment, testing |
Gcp
Board
Canvas
Checkpoint
Director
Assessment
Audit
Collaboration
Communication
Compliance
Who We AreBolt Biotherapeutics, based in the San Francisco Bay Area, is a clinical-stage biotechn...
View MoreWho We AreBolt Biotherapeutics, based in the San Francisco Bay Area, is a clinical-stage biotechn...
View MoreWho We AreBolt Biotherapeutics, based in the San Francisco Bay Area, is a clinical-stage biotechn...
View MoreWho We AreBolt Biotherapeutics, based in the San Francisco Bay Area, is a clinical-stage biotechn...
View MoreWho We AreBolt Biotherapeutics, based in the San Francisco Bay Area, is a clinical-stage biotechn...
View MoreWho We AreBolt Biotherapeutics, based in the San Francisco Bay Area, is a clinical-stage biotechn...
View MoreWho We AreBolt Biotherapeutics, based in the San Francisco Bay Area, is a clinical-stage biotechn...
View MoreWho We AreBolt Biotherapeutics, based in the San Francisco Bay Area, is a clinical-stage biotechn...
View MoreBolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing BoltbodyTM Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients. Bolts technology is appropriate for a broad spectrum of antibodies targeting tumor antigens expressed on all types of cancer and therefore applicable to many types of patients, including those who are refractory to the current generation of checkpoint inhibitors. The company is led by a...
Bolt biotherapeutics, inc operates in the Biotechnology industry.
Bolt biotherapeutics, inc's revenue is 1m - 10m
Bolt biotherapeutics, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.